| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |